Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
July 31, 2024 0.0106M
April 30, 2024 0.0118M
January 31, 2024 0.0148M
October 31, 2023 0.0117M
July 31, 2023 0.013M
April 30, 2023 0.0133M
January 31, 2023 0.023M
October 31, 2022 0.0566M
July 31, 2022 0.2069M
April 30, 2022 0.2152M
January 31, 2022 0.211M
October 31, 2021 0.3095M
July 31, 2021 0.4801M
April 30, 2021 0.2418M
January 31, 2021 0.1971M
October 31, 2020 0.039M
July 31, 2020 0.0853M
April 30, 2020 0.2316M
January 31, 2020 0.2495M
October 31, 2019 0.4181M
July 31, 2019 0.52M
April 30, 2019 0.101M
January 31, 2019 0.1091M
October 31, 2018 2.511M
July 31, 2018 2.520M
Date Value
April 30, 2018 3.234M
January 31, 2018 0.1436M
October 31, 2017 5.035M
July 31, 2017 0.1936M
April 30, 2017 0.102M
January 31, 2017 0.102M
October 31, 2016 0.176M
July 31, 2016 0.1758M
April 30, 2016 0.1767M
January 31, 2016 0.1775M
October 31, 2015 0.1803M
July 31, 2014 0.1814M
April 30, 2014 0.1776M
January 31, 2014 0.1791M
October 31, 2013 0.1838M
July 31, 2013 0.1928M
April 30, 2013 0.5539M
January 31, 2013 0.5729M
October 31, 2012 0.5731M
July 31, 2012 0.5954M
April 30, 2012 0.7805M
January 31, 2012 0.00
October 31, 2011 0.00
July 31, 2011 0.00
April 30, 2011 0.00

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Bespoke Extracts, Inc. 0.2956M
Carisma Therapeutics, Inc. 6.554M
Windtree Therapeutics, Inc. 15.98M
IDEXX Laboratories, Inc. 3.442B
Neogen Corp. 3.394B